Targeting DDR1 and DDR2 Overcomes Matrix-Mediated Melanoma Cell Adaptation to BRAF-targeted Therapy

doi 10.1101/857896
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Cold Spring Harbor Laboratory

Related search

BRAF Targeting Sensitizes Resistant Melanoma to Cytotoxic T Cells

Clinical Cancer Research
Cancer ResearchOncology
2019English

Discordancy in BRAF Mutations Among Primary and Metastatic Melanoma Lesions: Clinical Implications for Targeted Therapy

Modern Pathology
Forensic MedicinePathology
2014English

Combining Checkpoint Inhibitors and BRAF-targeted Agents Against Metastatic Melanoma

OncoImmunology
OncologyAllergyImmunology
2013English

Beyond BRAF: Where Next for Melanoma Therapy?

British Journal of Cancer
Cancer ResearchOncology
2014English

Inhibition of YAP Function Overcomes BRAF Inhibitor Resistance in Melanoma Cancer Stem Cells

Oncotarget
Oncology
2017English

Cessation of Targeted Therapy After a Complete Response in BRAF-mutant Advanced Melanoma: A Case Series

British Journal of Cancer
Cancer ResearchOncology
2016English

BRAF,NRASandKITsequencing Analysis of Spindle Cell Melanoma

Journal of Cutaneous Pathology
DermatologyForensic MedicinePathologyHistology
2012English

Adoptive T-Cell Transfer Therapy and Oncogene-Targeted Therapy for Melanoma: The Search for Synergy

Clinical Cancer Research
Cancer ResearchOncology
2013English

SOX2-mediated Upregulation of CD24 Promotes Adaptive Resistance Towards Targeted Therapy in Melanoma

International Journal of Cancer
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy